Concert Pharma (CNCE)

Concert Pharma (CNCE) – FDA

Feb 15, 2023 07:04 AM Concert Pharma (CNCE) Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA
Sep 12, 2022 05:22 AM Concert Pharma (CNCE) Reports Presentation of CTP-543 THRIVE-AA1 Phase 3 Data
Aug 22, 2022 07:10 AM
Aug 1, 2022 07:00 AM
Jun 7, 2022 07:01 AM
May 23, 2022 07:01 AM
May 23, 2022 07:00 AM
Jul 1, 2021 07:12 AM
Feb 1, 2021 07:01 AM
Nov 3, 2020 07:21 AM
Oct 29, 2020 10:00 AM
Oct 22, 2020 07:14 AM
Jul 8, 2020 07:03 AM
Jun 12, 2020 04:03 PM
Apr 1, 2020 07:01 AM
Dec 2, 2019 07:02 AM
Oct 14, 2019 06:19 AM
Sep 17, 2019 07:04 AM
Sep 12, 2019 07:01 AM
Sep 3, 2019 07:01 AM
Jun 12, 2019 07:03 AM
Apr 10, 2019 06:31 AM
Mar 6, 2019 07:12 AM
Jan 24, 2019 07:06 AM
Jan 22, 2019 07:02 AM
Nov 12, 2018 07:01 AM
Sep 26, 2018 07:07 AM
Feb 28, 2018 04:24 PM
Jan 12, 2018 07:07 AM
Jan 12, 2018 07:03 AM
Jul 10, 2017 07:31 AM
May 17, 2017 07:32 AM
May 2, 2017 06:33 AM
Apr 5, 2017 10:54 AM
Mar 6, 2017 07:01 AM
Jan 20, 2017 08:31 AM
Jan 17, 2017 07:04 AM
Dec 21, 2016 07:32 AM
Dec 14, 2016 07:35 AM
Jun 10, 2016 10:31 AM
May 19, 2016 07:09 AM
Feb 29, 2016 04:08 PM
Nov 12, 2015 07:05 AM
Sep 22, 2015 03:58 PM
Sep 22, 2015 11:01 AM
Jun 8, 2015 07:01 AM
May 18, 2015 10:10 AM
May 8, 2015 03:08 PM
Apr 1, 2015 08:51 AM
Dec 9, 2014 08:38 AM